Amidoxime-phosphonate / phosphinic acid compound and preparation method and application thereof

By developing geminoxime-phosphonate/phosphinic acid compounds as uranyl ion extractants, the problem of low-concentration uranyl ion extraction efficiency in low-grade uranyl ores is solved by using their chelating ability with uranyl ions. , achieving efficient uranyl ion recovery.

CN115636850BActive Publication Date: 2024-12-03NANHUA UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211192881.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-09-28
Publication Date
2024-12-03
Estimated Expiration
2042-09-28

AI Technical Summary

Technical Problem

The prior art has low extraction efficiency of low-concentrated uranyl ions in low-grade uranyl acid leaching liquid, making it difficult to effectively recover uranium resources.

Method used

Amidoxime-phosphonate/phosphinic acid compound was developed as uranyl ion extractant, and amidoxime group and phosphinate were produced by substitution reaction of halogenated amidoxime and trialkyl phosphite. Extracting agents for phosphonic acid groups use these groups to form a chelating structure with uranyl ions to improve the extraction efficiency.

Benefits of technology

The extraction rate of low-concentrated uranyl ions in the acidic leaching liquid of low-grade uranyl ore has been significantly improved, and the efficient recovery of uranyl ions is achieved, which is suitable for industrial applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115636850B_ABST
    Figure CN115636850B_ABST
Patent Text Reader

Abstract

The present invention provides amidoxime-phosphonate / phosphinic acid compounds and preparation methods and applications thereof. A halogenated amidoxime is subjected to substitution reaction with a trialkyl phosphite to obtain an amidoxime-phosphonate, and then subjected to saponification reaction, acidification, extraction and reduced pressure distillation to obtain an amidoxime-phosphinic acid, and for the first time, a uranyl ion extractant having both an amidoxime group and a phosphoryl group is obtained. The amidoxime group is a targeted functional group of the uranyl ion, and forms a five-membered ring with the uranyl ion through oxygen atoms and nitrogen atoms. The phosphonate / phosphinic acid group can partially or completely react with the uranyl ion to form a P-O-U bond or a P-O-U-O-P-chelate ring, and the ability of the two groups to synergistically chelate uranyl ions is enhanced, which greatly increases the extraction and recovery of uranyl ions in acidic leaching solutions of ores, and is particularly suitable for the extraction and recovery of low-concentration uranyl ions in acidic leaching solutions of low-grade ores. The extraction and recovery process is simple, efficient, and feasible, meeting the requirements of industrial applications.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of metal ion extraction technology, and in particular to amidoxime-phosphonate / phosphinic acid compounds and preparation methods and applications thereof. Background Art

[0002] The ecological and environmental problems caused by the combustion of traditional fuels are becoming increasingly prominent, and the development of clean and efficient energy is imminent. Uranium is an important raw material for obtaining clean and efficient energy. The mining and beneficiation of uranium ore is one of the main ways to quickly and safely obtain uranium products. With the rapid development of the atomic energy industry, most of the high-grade uranium mines have been basically mined, and the mining research of lower-grade uranium mines has become an important task in the current development of uranium resources. At present, sulfuric acid leaching of uranium ore is the most commonly used method for uranium mining and metallurgy. Solvent extraction is an effective means of enriching and recovering uranium from uranium acid leachate. The extractant is the key factor that determines the extraction and enrichment of uranium. Therefore, it is of great significance to design and develop an efficient extractant for extracting low-concentration uranyl ions from high-acidity uranium acid leachate.

[0003] Alkylphosphonic acid is a common extractant for uranium extraction. It can exist stably under acidic conditions and has high acid resistance. However, this type of extractant often exists in the form of a dimer, with only one hydrogen ion in the molecule participating in the exchange. The extraction distribution ratio for uranyl ions is low, and the extraction capacity is not high. Bifunctional extractants containing phosphorus (phosphonic acid) groups, such as O-alkyl-dialkyl-phosphine oxide-O'-alkyl-2-alkyl phosphoric acid (see structural formula a), amide-phosphonic acid (see structural formula b), amide-phosphinic acid (see structural formula c) and amide-phosphonic acid esters (see structural formula d), can effectively reduce the amount of extractant used and improve the extraction distribution coefficient and selectivity for uranium.

[0004]

[0005]

[0006] These bifunctional extractants containing phosphorus (phosphonic) acid groups can effectively reduce the amount of extractants used and improve the extraction distribution coefficient and selectivity for uranium. However, the extraction distribution ratio for low-concentration uranium is not high, and the problem of extracting low-concentration uranyl ions in acidic leaching solutions of low-grade uranium ore is still not well solved. Summary of the invention

[0007] The object of the present invention is to provide an amidoxime-phosphonate / phosphinic acid compound and a preparation method and application thereof in view of the above-mentioned deficiencies in the prior art. The extractant can stably exist under relatively high acidity and can form a relatively strong complex with uranyl ions, and is particularly suitable for the efficient extraction and recovery of uranyl ions in the high-acidity leaching solution of low-grade uranium ore.

[0008] To achieve the above object, the present invention adopts the following technical solution:

[0009] The first object of the present invention is to provide an amidoxime-phosphonate / phosphinic acid compound, characterized in that the chemical structure is as shown in formula (I):

[0010]

[0011] Wherein, R1 is selected from H, C1-C 16 Alkyl, C6-C 10 The aromatic and C7-C 16 Any one of the aralkyl groups; R2 is selected from C1-C 16 Alkyl, C6-C 10 Aryl, C7-C 16 Aralkyl, C1-C 16 Alkoxy, C6-C 10 The aryloxy and C7-C 16 Any one of the aralkyloxy groups; R3 is a C1-C3 hydrocarbon group.

[0012] Further, the R1 is selected from any one of hydrogen, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, phenyl, p-tolyl, n-octyl, isooctyl, sec-octyl, 2-ethylhexyl, n-decyl or isodecyl.

[0013] Further, R2 is selected from any one of ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, phenyl, p-tolyl, n-octyl, isooctyl, sec-octyl, 2-ethylhexyl, n-decyl, isodecyl, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec-butoxy, pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, phenoxy, p-tolyl, n-octyl, isooctyl, sec-octyl, 2-ethylhexyloxy, n-decyl, or isodecyl.

[0014] Furthermore, the R3 is methylene or 1,2-ethylene.

[0015] The implementation method is: when R3 is methylene, R1 is ethyl, and R2 is ethoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diethyl ester;

[0016] When R3 is methylene, R1 is propyl, and R2 is propoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid dipropyl ester;

[0017] When R3 is methylene, R1 is isopropyl, and R2 is isopropoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisopropyl ester;

[0018] When R3 is methylene, R1 is butyl, and R2 is butoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid dibutyl ester;

[0019] When R3 is methylene, R1 is isobutyl, and R2 is isobutyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisobutyl ester;

[0020] When R3 is methylene, R1 is sec-butyl, and R2 is sec-butoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-sec-butyl ester;

[0021] When R3 is methylene, R1 is pentyl, and R2 is pentyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid dipentyl ester;

[0022] When R3 is methylene, R1 is isopentyl, and R2 is isopentyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisopentyl ester;

[0023] When R3 is methylene, R1 is neopentyl, and R2 is neopentyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid dineopentyl ester;

[0024] When R3 is methylene, R1 is n-hexyl, and R2 is n-hexyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-n-hexyl ester;

[0025] When R3 is methylene, R1 is isohexyl, and R2 is isohexyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisohexyl ester;

[0026] When R3 is methylene, R1 is phenyl, and R2 is phenoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl) diphenyl phosphonate;

[0027] When R3 is methylene, R1 is p-tolyl, and R2 is p-tolyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-p-tolyl ester;

[0028] When R3 is methylene, R1 is n-octyl, and R2 is n-octyloxy, formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-n-octyl ester;

[0029] When R3 is methylene, R1 is isooctyl, and R2 is isooctyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisooctyl ester;

[0030] When R3 is methylene, R1 is secondary octyl, and R2 is secondary octyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-secondary octyl ester;

[0031] When R3 is methylene, R1 is 2-ethylhexyl, and R2 is 2-ethylhexyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid bis(2-ethylhexyl) ester;

[0032] When R3 is methylene, R1 is n-decyl, and R2 is n-decyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-n-decyl ester;

[0033] When R3 is methylene, R1 is isodecyl, and R2 is isodecyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisodecyl ester;

[0034] When R3 is methylene, R1 is hydrogen, and R2 is ethoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen ethyl ester;

[0035] When R3 is methylene, R1 is hydrogen, and R2 is propoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen propyl ester;

[0036] When R3 is methylene, R1 is hydrogen, and R2 is isopropoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid isopropyl hydrogen ester;

[0037] When R3 is methylene, R1 is hydrogen, and R2 is butoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)butyl hydrogen phosphonate;

[0038] When R3 is methylene, R1 is hydrogen, and R2 is isobutyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen isobutyl ester;

[0039] When R3 is methylene, R1 is hydrogen, and R2 is sec-butyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid sec-butyl hydrogen ester;

[0040] When R3 is methylene, R1 is hydrogen, and R2 is pentyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen pentyl ester;

[0041] When R3 is methylene, R1 is hydrogen, and R2 is isopentyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen isopentyl ester;

[0042] When R3 is methylene, R1 is hydrogen, and R2 is neopentyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen neopentyl ester;

[0043] When R3 is methylene, R1 is hydrogen, and R2 is n-hexyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen n-hexyl ester;

[0044] When R3 is methylene, R1 is hydrogen, and R2 is isohexyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen isohexyl ester;

[0045] When R3 is methylene, R1 is hydrogen, and R2 is phenoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phenyl hydrogen phosphonate;

[0046] When R3 is methylene, R1 is hydrogen, and R2 is p-tolyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid p-tolyl ester;

[0047] When R3 is methylene, R1 is hydrogen, and R2 is n-octyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen n-octyl ester;

[0048] When R3 is methylene, R1 is hydrogen, and R2 is isooctyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen isooctyl ester;

[0049] When R3 is methylene, R1 is hydrogen, and R2 is sec-octyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid sec-octyl hydrogen ester;

[0050] When R3 is methylene, R1 is hydrogen, and R2 is 2-ethylhexyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid 2-ethylhexyl ester;

[0051] When R3 is methylene, R1 is hydrogen, and R2 is n-decyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen n-decyl ester;

[0052] When R3 is methylene, R1 is hydrogen, and R2 is isodecyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid hydrogen isodecyl ester;

[0053] When R3 is methylene, R1 is hydrogen, and R2 is ethyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(ethyl)phosphinic acid;

[0054] When R3 is methylene, R1 is hydrogen, and R2 is propyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(propyl)phosphinic acid;

[0055] When R3 is methylene, R1 is hydrogen, and R2 is isopropyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(isopropyl)phosphinic acid;

[0056] When R3 is methylene, R1 is hydrogen, and R2 is isobutyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(isobutyl)phosphinic acid;

[0057] When R3 is methylene, R1 is hydrogen, and R2 is sec-butyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(sec-butyl)phosphinic acid;

[0058] When R3 is methylene, R1 is hydrogen, and R2 is pentyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(pentyl)phosphinic acid;

[0059] When R3 is methylene, R1 is hydrogen, and R2 is n-hexyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(n-hexyl)phosphinic acid;

[0060] When R3 is methylene, R1 is hydrogen, and R2 is cyclohexyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(cyclohexyl)phosphinic acid;

[0061] When R3 is methylene, R1 is hydrogen, and R2 is phenyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(phenyl)phosphinic acid;

[0062] When R3 is methylene, R1 is hydrogen, and R2 is p-tolyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(p-tolyl)phosphinic acid;

[0063] When R3 is methylene, R1 is hydrogen, and R2 is nonyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(nonyl)phosphinic acid;

[0064] When R3 is methylene, R1 is hydrogen, and R2 is n-decyl, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)(n-decyl)phosphinic acid;

[0065] When R3 is 1,2-ethylene, R1 is isopropyl, and R2 is isopropoxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phosphonic acid diisopropyl ester;

[0066] When R3 is 1,2-ethylene, R1 is butyl, and R2 is butoxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phosphonic acid dibutyl ester;

[0067] When R3 is 1,2-ethylene, R1 is isobutyl, and R2 is isobutyloxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phosphonic acid diisobutyl ester;

[0068] When R3 is 1,2-ethylene, R1 is phenyl, and R2 is phenoxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl) diphenyl phosphonate;

[0069] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is isopropoxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phosphonic acid isopropyl hydrogen ester;

[0070] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is butoxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl) butyl hydrogen phosphonate;

[0071] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is isobutyloxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phosphonic acid hydrogen isobutyl ester;

[0072] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is phenoxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phenyl hydrogen phosphonate;

[0073] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is ethyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(ethyl)phosphinic acid;

[0074] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is propyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(propyl)phosphinic acid;

[0075] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is isopropyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(isopropyl)phosphinic acid;

[0076] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is isobutyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(isobutyl)phosphinic acid;

[0077] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is sec-butyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(sec-butyl)phosphinic acid;

[0078] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is pentyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(pentyl)phosphinic acid;

[0079] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is n-hexyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(n-hexyl)phosphinic acid;

[0080] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is cyclohexyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(cyclohexyl)phosphinic acid;

[0081] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is phenyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(phenyl)phosphinic acid;

[0082] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is p-tolyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(p-tolyl)phosphinic acid;

[0083] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is nonyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(nonyl)phosphinic acid;

[0084] When R3 is 1,2-ethylene, R1 is hydrogen, and R2 is n-decyl, the formula (I) is (3-amino-3-(hydroxyimino)propyl)(n-decyl)phosphinic acid.

[0085] The second object of the present invention is to provide a method for preparing the above amidoxime-phosphonate / phosphinic acid compound, wherein a halogenated amidoxime and a trialkyl phosphite are subjected to a substitution reaction, the molar ratio of the halogenated amidoxime to the trialkyl phosphite is 1:(0.8-10), the reaction temperature is 140-170°C, and the reaction time is 2-10 hours, to generate an amidoxime-phosphonate compound of formula I, wherein the amidoxime-phosphonate compound of formula I undergoes a saponification reaction with a sodium hydroxide solution in 1,4-dioxane, and is acidified, extracted, and distilled under reduced pressure to obtain an amidoxime-phosphinic acid compound, wherein the structure of the halogenated amidoxime is shown in formula (II), and the structure of the trialkyl phosphite is shown in formula (III):

[0086]

[0087] The third object of the present invention is to provide the use of the amidoxime-phosphonate / phosphinic acid compound in the preparation of a uranyl ion extractant.

[0088] The fourth object of the present invention is to provide a method for extracting low-concentration uranyl ions in an acidic leaching solution of a uranium ore. In the extraction system, the above-mentioned amidoxime-phosphonate / phosphinic acid compound is used as an organic phase, and the uranyl ions in the acidic leaching solution of the uranium ore enter the organic phase from the aqueous phase to achieve uranium extraction, which specifically comprises the following steps:

[0089] S1, preparing an organic phase, dissolving an amidoxime-phosphonate / phosphinic acid compound in a diluent to obtain an organic phase;

[0090] S2, preparing an aqueous phase, placing the uranium ore in a solution containing an inorganic acid for leaching, and obtaining an aqueous phase - an acidic leaching solution containing uranium;

[0091] S3, the organic phase obtained in step S1 and the aqueous phase obtained in step S2 are mixed in a volume ratio of 1: (0.1-10), stirred at 25-30° C., at a stirring speed of 250-300 r / min, and stirred for 5-60 min, so that the uranyl ions enter the organic phase from the aqueous phase, that is, the uranyl ions are extracted.

[0092] Furthermore, in step S1, the concentration of the amidoxime-phosphonate / phosphinic acid compound in the organic phase is 0.1-2M; and the diluent is selected from any one of kerosene, dodecane, xylene and sulfonated kerosene.

[0093] Furthermore, in step S2, the mass concentration range of uranyl ions in the uranium ore acidic leaching solution is 0.01-200 mg / L; the uranium ore acidic leaching solution is any one of a uranium ore concentrated acid maturation stirring leaching solution and a uranium ore high acid enhanced heap leaching leaching solution, and the uranium ore includes a low-grade uranium ore or a uranium associated ore.

[0094] Furthermore, the concentration of the inorganic acid in the aqueous phase is 1-5 M, and the inorganic acid is selected from any one of hydrochloric acid, nitric acid, sulfuric acid and phosphoric acid.

[0095] Compared with the prior art, the technical solution provided by the present invention has the following beneficial effects:

[0096] The present invention provides amidoxime-phosphonate / phosphinic acid compounds and preparation methods and applications thereof, wherein halogenated amidoxime and trialkyl phosphite are subjected to substitution reaction to obtain amidoxime-phosphonate. The molar ratio of halogenated amidoxime to trialkyl phosphite is 1:(0.8-10), the reaction temperature is 140-170°C, the reaction time is 2-10 hours, and a uranyl ion extractant having an amidoxime-phosphonate structure is generated. The extractant undergoes a saponification reaction with a sodium hydroxide solution in 1,4-dioxane, and is subjected to acidification, extraction, and reduced pressure distillation to obtain amidoxime-phosphinic acid. For the first time, a type of uranyl ion extractant having both an amidoxime group and a phosphoryl group is obtained, and the uranyl ion extractant has both Amidoxime and phosphonate / phosphinate functional groups. Amidoxime is a targeted functional group of uranyl ions. It can form a five-membered ring with uranyl ions through oxygen and nitrogen atoms in the structure, while phosphonate / phosphinate groups can partially or completely form POU bonds or -POUOP- chelate rings with uranyl ions. The synergistic chelation ability of the two groups to uranyl ions is enhanced, which greatly increases the extraction and recovery of uranyl ions in acidic leaching solutions of ores, and is particularly suitable for the extraction and recovery of low-concentration uranyl ions in acidic leaching solutions of low-grade ores. The uranyl ion extraction and recovery process is simple, efficient, and feasible, meeting the requirements of industrial applications. BRIEF DESCRIPTION OF THE DRAWINGS

[0097] Figure 1 The infrared spectrum of (2-amino-2-(hydroxyimino)ethyl)butylphosphinic acid prepared in Example 1;

[0098] Figure 2 The infrared spectrum of phenyl hydrogen-(2-amino-2-(hydroxyimino)ethyl)phosphonate prepared in Example 2;

[0099] Figure 3 The infrared spectrum of 2-ethylhexyl hydrogen-(2-amino-2-(hydroxyimino)ethyl)phosphonate prepared in Example 3;

[0100] Figure 4 This is the infrared spectrum of diphenyl (2-amino-2-(hydroxyimino)ethyl)phosphonate obtained in Example 4. DETAILED DESCRIPTION

[0101] In order to make the purpose, technical scheme and advantages of the present invention clearer, the specific embodiments of the present invention are further described in detail below in conjunction with specific examples and drawings. If no specific technology or conditions are specified in the examples, the technology or conditions described in the literature in this field or the product instructions are used. If the manufacturer of the reagents or instruments is not specified, they are all conventional products that can be obtained commercially.

[0102] Example 1

[0103] Preparation of (2-amino-2-(hydroxyimino)ethyl)butylphosphinic acid

[0104]

[0105] 5.40 parts of chloroethylamide oxime were added to 12.52 parts of tributyl phosphite at 160°C under stirring, and stirred at 160°C for 3 hours after the addition. Then, it was reacted with 8 parts of sodium hydroxide solution in 60 parts of 1,4-dioxane for 4 hours, acidified with 3M HCl to pH 6, extracted twice with 30mL of ether, and distilled under reduced pressure at 100°C until no liquid evaporated to obtain (2-amino-2-(hydroxyimino)ethyl)butylphosphinic acid, the structural formula of which is shown in Formula 1, and its infrared spectrum is shown in Figure 1 The yield was 95%.

[0106] Example 2

[0107] Preparation of phenyl hydrogen-(2-amino-2-(hydroxyimino)ethyl)phosphonate

[0108]

[0109] 5.40 parts of chloroethylamide oxime were added to 15.83 parts of triphenyl phosphite at 140°C under stirring, and the mixture was stirred and reacted at 140°C for 3 hours. The mixture was acidified to pH 6 with 3M HCl, extracted twice with 30 mL of ether, and distilled under reduced pressure at 100°C until no liquid evaporated to obtain phenyl hydrogen-(2-amino-2-(hydroxyimino)ethyl)phosphonate, the structural formula of which is shown in Formula 2, and the infrared spectrum of which is shown in Figure 2 The yield was 96%.

[0110] Example 3

[0111] Preparation of 2-ethylhexyl hydrogen-(2-amino-2-(hydroxyimino)ethyl)phosphonate

[0112]

[0113] 5.40 parts of chloroethylamide oxime were added to 23.26 parts of triethylhexyl phosphite at 160°C under stirring, and the mixture was stirred and reacted at 160°C for 3 hours. The mixture was acidified to pH 6 with 3M HCl, extracted twice with 30 mL of ether, and distilled under reduced pressure at 100°C until no liquid evaporated to obtain 2-ethylhexyl hydrogen-(2-amino-2-(hydroxyimino)ethyl)phosphonate, the structural formula of which is shown in Formula 3, and the infrared spectrum of which is shown in Figure 3 The yield was 96%.

[0114] Example 4

[0115] Preparation of diphenyl (2-amino-2-(hydroxyimino)ethyl)phosphonate

[0116]

[0117] 5.40 parts of chloroethenamide oxime were added to 15.83 parts of triphenyl phosphite at 170°C under stirring, and stirred at 170°C for 3 hours. Then, it was reacted with 8 parts of sodium hydroxide solution in 60 parts of 1,4-dioxane for 4 hours to obtain (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diphenyl ester, the structural formula of which is shown in Formula 4, and its infrared spectrum is shown in Figure 4 The yield was 96%.

[0118] In Examples 5 to 8, the extractants having the amidoxime-phosphonate / phosphinic acid compound structure prepared in Examples 1 to 4 are used to extract and recover uranyl ions in a simulated uranyl ion solution.

[0119] Preparation process of simulated uranyl ion solution: accurately weigh 1.274 g of analytical pure uranyl nitrate hexahydrate, dissolve it in a volumetric flask, make up to 1 L, prepare a 1 mg / mL uranyl ion standard stock solution, and then use inorganic acid.

[0120] The determination process and calculation formula of the uranyl ion extraction rate obtained in Examples 5 to 8 are as follows: The concentration of uranyl ions in the aqueous phase before and after extraction was determined by spectrophotometry using azoarsenazo III color reaction, which were recorded as C0 and C1 respectively. r The calculation formula of extraction rate is:

[0121]

[0122] Example 5

[0123] Extraction of Uranyl Ions by (2-Amino-2-(Hydroxyimino)ethyl)butylphosphinic Acid

[0124] (2-Amino-2-(hydroxyimino)ethyl)butylphosphinic acid was prepared with a diluent to form an extraction organic phase with a concentration of 0.2M, and the diluent was kerosene; the initial concentration of uranyl ions in the aqueous phase was 120 mg / L, and sulfuric acid was dissolved until the concentration of sulfuric acid in the aqueous phase was 2M; the volume ratio of the organic phase to the aqueous phase was 1:3, and the extraction was carried out at 30°C for 1 hour, and the uranyl ion extraction rate reached 98.7%.

[0125] Example 6

[0126] Extraction of Uranyl Ions by Phenyl Hydrogen-(2-Amino-2-(Hydroxyimino)ethyl)phosphonate

[0127] Phenyl hydrogen-(2-amino-2-(hydroxyimino)ethyl)phosphonate was prepared with a diluent to form an extraction organic phase with a concentration of 0.2M, and the diluent was dodecane; the initial concentration of uranyl ions in the aqueous phase was 100 mg / L, and it was dissolved with hydrochloric acid until the concentration of hydrochloric acid in the aqueous phase was 3M; the volume ratio of the organic phase to the aqueous phase was 1:3, and the extraction was carried out at 30°C for 1 hour, and the uranyl ion extraction rate reached 96.3%.

[0128] Example 7

[0129] Extraction of Uranyl Ions by 2-Ethylhexyl Hydrogen-(2-Amino-2-(Hydroxyimino)ethyl)phosphonate

[0130] 2-Ethylhexyl hydrogen-(2-amino-2-(hydroxyimino)ethyl)phosphonate was prepared with a diluent to prepare an organic phase with a concentration of 0.1 M, and the diluent was xylene; the initial concentration of uranyl ions in the aqueous phase was 50 mg / L, and nitric acid was used to dissolve the uranyl ions until the concentration of nitric acid in the aqueous phase was 3 M; the volume ratio of the organic phase to the aqueous phase was 1:5, and the extraction was carried out at 30°C for 1 hour, and the uranyl ion extraction rate reached 97.1%.

[0131] Example 8

[0132] Extraction of Uranyl Ions by Diphenyl (2-Amino-2-(Hydroxyimino)ethyl)phosphonate

[0133] (2-Amino-2-(hydroxyimino)ethyl)phosphonic acid diphenyl ester was prepared with a diluent to form an extraction organic phase with a concentration of 0.2M, and the diluent was sulfonated kerosene; the initial concentration of uranyl ions in the aqueous phase was 200 mg / L, and phosphoric acid was used to dissolve it until the concentration of phosphoric acid in the aqueous phase was 5M; the volume ratio of the organic phase to the aqueous phase was 1:3, and the extraction was carried out at 30°C for 1 hour, and the uranyl ion extraction rate reached 94.5%.

[0134] In order to better illustrate the effect of the amidoxime-phosphonate / phosphinic acid compound of the present invention in extracting and recovering low-concentration uranyl ions in the acidic leachate of uranium ore, the applicant has also conducted a specific application.

[0135] Example 9

[0136] The extractant having the amidoxime-phosphonate / phosphinic acid compound structure prepared in Example 3 is used to extract and recover low-concentration uranyl ions in the acidic leaching solution of uranium ore.

[0137] Uranium ore acidic leaching solution: mainly divided into concentrated acid matured stirring leaching solution of uranium ore and high acid enhanced heap leaching solution of uranium ore. Concentrated acid matured stirring leaching solution is to first crush the uranium-containing ore to a particle size of less than 20mm, then mix, reduce and further process the crushed ore using crushing equipment and ball mill; then weigh a certain amount of ore sample with a particle size of less than 0.15mm, fix the liquid-solid volume mass ratio under normal temperature stirring conditions, acid-leach the sample for a certain period of time, filter, and obtain the uranium-containing acidic leaching solution. High acid enhanced heap leaching solution is to take the crushed ore with a particle size of less than 5mm for column loading, then spray the ore sample with acid solutions of different concentrations, and collect the leaching solution.

[0138] The uranium ore acid leaching solution used in this embodiment is a concentrated acid slaking stirring leaching solution. The uranium ore is collected from Xiangshan uranium mine in Jiangxi Province, with a grade of about 0.03%. The main chemical components of the ore are U 0.018%, SiO280.963%, Al2O3 6.503%, Fe2O3 1.348%, CaO 3.711%, MgO 1.012%, K2O1.573%, and Na2O 0.296%. The specific preparation is: the uranium ore is crushed by a laboratory jaw crusher, a ball mill, etc., and a 200-mesh sieve is passed to obtain a uranium ore powder with a particle size less than 0.038mm. Take 100g of uranium ore powder with a particle size less than 0.038mm, add 400mL of water, 27mL of concentrated sulfuric acid, and 2g of sodium chlorate respectively, and stir for 5h at 90°C to obtain a uranium content of about 70mg / L in the leaching solution, and a sulfuric acid concentration of about 1.5M.

[0139] Extraction of Uranyl Ions by 2-Ethylhexyl (2-Amino-2-(Hydroxyimino)ethyl)phosphonate

[0140] 2-Ethylhexyl hydrogen-(2-amino-2-(hydroxyimino)ethyl)phosphonate was prepared with a diluent to form an extraction organic phase with a concentration of 0.1M, and the diluent was dodecane; the uranium content in the uranium ore acid leaching solution was 70mg / L, and the sulfuric acid concentration was about 1.5M; the volume ratio of the organic phase to the aqueous phase was 5:1, and the extraction was performed at 30°C for 30 minutes, and the uranyl ion extraction rate reached 95.5%.

[0141] Example 10

[0142] Uranium ore acid leaching solution: same as Example 9.

[0143] The extractant is: bis(2-ethylhexyl)(2-amino-2-(hydroxyimino)ethyl)phosphonate.

[0144] Preparation process of bis(2-ethylhexyl)(2-amino-2-(hydroxyimino)ethyl)phosphonate: 5.40 parts of chloroethyl amidoxime are added to 23.26 parts of triethylhexyl phosphite under stirring, and after the addition, the mixture is stirred and reacted at 160°C for 3 hours. Bis(2-ethylhexyl)(2-amino-2-(hydroxyimino)ethyl)phosphonate is obtained, and its structural formula is shown in Formula 5.

[0145]

[0146] Extraction of uranyl ions using bis(2-ethylhexyl)(2-amino-2-(hydroxyimino)ethyl)phosphonate:

[0147] 2-Ethylhexyl hydrogen-(2-amino-2-(hydroxyimino)ethyl)phosphonate-2-ethylhexyl ester was prepared with a diluent to form an extraction organic phase with a concentration of 0.1M, and the diluent was dodecane; the uranium content in the uranium ore leaching solution was 70 mg / L, and the sulfuric acid concentration was about 1.5 M; the volume ratio of the organic phase to the aqueous phase was 5:1, and the extraction was performed at 30°C for 30 minutes, and the uranyl ion extraction rate reached 83.3%.

[0148] Comparative Example 1

[0149] Extraction of Uranyl Ions by Mono-2-Ethylhexyl (2-Ethylhexyl) Phosphate

[0150]

[0151] (2-ethylhexyl) phosphate mono-2-ethylhexyl ester was prepared with a diluent to form an extraction organic phase with a concentration of 0.1M, and the diluent was dodecane; the uranium content in the uranium ore leaching solution was 70mg / L, and the sulfuric acid concentration was about 1.5M; the volume ratio of the organic phase to the aqueous phase was 5:1, and the extraction was carried out at 30°C for 30 minutes, and the uranyl ion extraction rate reached 72.4%.

[0152] In the absence of conflict, the above embodiments and features in the embodiments may be combined with each other.

[0153] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. An amidoxime-phosphonate compound, characterized in that: The chemical structure is shown in formula (I): (Ⅰ) Wherein, when R3 is methylene, R1 is propyl, and R2 is propoxy, formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid dipropyl ester; When R3 is methylene, R1 is isopropyl, and R2 is isopropoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisopropyl ester; When R3 is methylene, R1 is butyl, and R2 is butoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid dibutyl ester; When R3 is methylene, R1 is isobutyl, and R2 is isobutyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisobutyl ester; When R3 is methylene, R1 is sec-butyl, and R2 is sec-butoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-sec-butyl ester; When R3 is methylene, R1 is pentyl, and R2 is pentyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid dipentyl ester; When R3 is methylene, R1 is isopentyl, and R2 is isopentyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisopentyl ester; When R3 is methylene, R1 is neopentyl, and R2 is neopentyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid dineopentyl ester; When R3 is methylene, R1 is n-hexyl, and R2 is n-hexyloxy, formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-n-hexyl ester; When R3 is methylene, R1 is isohexyl, and R2 is isohexyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisohexyl ester; When R3 is methylene, R1 is phenyl, and R2 is phenoxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl) diphenyl phosphonate; When R3 is methylene, R1 is p-tolyl, and R2 is p-tolyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-p-tolyl ester; When R3 is methylene, R1 is n-octyl, and R2 is n-octyloxy, formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-n-octyl ester; When R3 is methylene, R1 is isooctyl, and R2 is isooctyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisooctyl ester; When R3 is methylene, R1 is secondary octyl, and R2 is secondary octyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-secondary octyl ester; When R3 is methylene, R1 is 2-ethylhexyl, and R2 is 2-ethylhexyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid bis(2-ethylhexyl) ester; When R3 is methylene, R1 is n-decyl, and R2 is n-decyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid di-n-decyl ester; When R3 is methylene, R1 is isodecyl, and R2 is isodecyloxy, the formula (I) is (2-amino-2-(hydroxyimino)ethyl)phosphonic acid diisodecyl ester; When R3 is 1,2-ethylene, R1 is propyl, and R2 is propoxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phosphonic acid dipropyl ester; When R3 is 1,2-ethylene, R1 is isopropyl, and R2 is isopropoxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phosphonic acid diisopropyl ester; When R3 is 1,2-ethylene, R1 is butyl, and R2 is butoxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phosphonic acid dibutyl ester; When R3 is 1,2-ethylene, R1 is isobutyl, and R2 is isobutyloxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phosphonic acid diisobutyl ester; When R3 is 1,2-ethylene, R1 is phenyl, and R2 is phenoxy, the formula (I) is (3-amino-3-(hydroxyimino)propyl)phosphonic acid diphenyl ester.

2. The method for preparing the amidoxime-phosphonate compound according to claim 1, wherein: The haloamidoxime and trialkyl phosphite are subjected to substitution reaction, the molar ratio of the haloamidoxime to the trialkyl phosphite is 1:(0.8-10), the reaction temperature is 140-170°C, and the reaction time is 2-10 hours to generate an amidoxime-phosphonate compound of the structure of formula I.

3. Use of the amidoxime-phosphonate compound as claimed in claim 1 in the preparation of a uranyl ion extractant.

4. A method for extracting uranyl ions from an acidic leaching solution of a uranium ore, characterized in that: In the extraction system, the amidoxime-phosphonate compound as claimed in claim 1 is used as the organic phase, and the uranyl ions in the uranium ore acidic leaching solution enter the organic phase from the aqueous phase to achieve uranium extraction, which specifically includes the following steps: S1, preparing an organic phase, dissolving the amidoxime-phosphonate compound in a diluent to obtain an organic phase; S2, preparing an aqueous phase, placing the uranium ore in a solution containing an inorganic acid for leaching, and obtaining an aqueous phase - an acidic leaching solution containing uranium; S3, mixing the organic phase obtained in step S1 with the aqueous phase obtained in step S2 in a volume ratio of 1:(0.1-10), stirring at 25-30°C, with a stirring speed of 250-300 r / min, stirring for 5-60 min, and allowing the uranyl ions to enter the organic phase from the aqueous phase, i.e., extracting the uranyl ions.

5. The method according to claim 4, characterized in that In step S1, the The concentration of the amidoxime-phosphonate compound in the organic phase is 0.1-2 M; and the diluent is selected from any one of kerosene, dodecane, xylene and sulfonated kerosene.

6. The method according to claim 5, characterized in that In step S2, the The mass concentration range of uranyl ions in the uranium ore acidic leaching solution is 0.01-200 mg / L; the uranium ore acidic leaching solution is any one of a uranium ore concentrated acid maturation stirring leaching solution and a uranium ore high acid enhanced heap leaching leaching solution, and the uranium ore includes a low-grade uranium ore or a uranium associated ore.

7. The method according to claim 6, characterized in that The concentration of the inorganic acid in the aqueous phase is 1-5 M, and the inorganic acid is selected from any one of hydrochloric acid, nitric acid, sulfuric acid and phosphoric acid.